Estimate of the cost of multiple sclerosis in Spain by literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimate of the cost of multiple sclerosis in Spain by literature review

Published:2017-07-04 Issue:4 Volume:17 Page:321-333
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Fernández Oscar¹,Calleja-Hernández Miguel Angel²,Meca-Lallana José³,Oreja-Guevara Celia⁴,Polanco Ana⁵,Pérez-Alcántara Ferran⁶

Affiliation:

1. Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Málaga, Spain

2. Hospital Universitario Virgen Macarena, Sevilla, Spain

3. Multiple Sclerosis Unit, Department of Neurology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain

4. Hospital Clínico San Carlos, Madrid, Spain

5. Market Access and Corporate Affairs, Merck Group, Madrid, Spain

6. Oblikue Consulting S.L., Barcelona, Spain

Funder

Merck Group

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2017.1358617

Reference75 articles.

1. Multiple sclerosis

2. Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain

3. Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture–recapture method

4. Estudio epidemiológico de la esclerosis múltiple en La Rioja

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study;Multiple Sclerosis and Related Disorders;2024-10

2. Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review;Health Economics Review;2024-02-16

3. The Effectiveness of a Single Dry Needling Session on Gait and Quality of Life in Multiple Sclerosis: A Double-Blind Randomized Sham-Controlled Pilot Trial;Healthcare;2023-12-19

4. Cost–effectiveness of cladribine tablets and dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis in Spain;Journal of Comparative Effectiveness Research;2023-02

5. Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain;Journal of Medical Economics;2022-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3